Table 4. Relationship between ploidy status, age, and smoke habit, in OPMDsa and OSCCsb patients.
DNA aneuploidy in patients with OPMDs or OSCCs | Odds Ratio | P-valuec | Lower 95% Confidence interval | Upper 95% Confidence interval |
---|---|---|---|---|
All patients | ||||
Age | 1.03 | 0.027 | 1.00 | 1.05 |
OSCCs vs OPMDs | 8.28 | <0.0005 | 4.01 | 17.1 |
Multiple vs single oral subsite OPMDs/OSCCs | 0.35 | 0.007 | 0.16 | 0.75 |
Smokers vs Non-smokers | 0.73 | 0.397 | 0.35 | 1.51 |
Drinkers vs Non-drinkers | 1.11 | 0.770 | 0.56 | 2.21 |
Gender (female vs male) | 0.78 | 0.507 | 0.38 | 1.62 |
OPMD patients | ||||
Age | 1.03 | 0.051 | 1.00 | 1.06 |
D-OPMDsd vs ND-OPMDse | 3.08 | 0.017 | 1.22 | 7.76 |
Multiple vs single oral subsite OPMDs | 0.21 | 0.008 | 0.07 | 0.67 |
Smokers vs Non-smokers | 1.51 | 0.391 | 0.59 | 3.90 |
Drinkers vs Non-drinkers | 1.19 | 0.693 | 0.51 | 2.78 |
Gender (female vs male) | 0.77 | 0.568 | 0.32 | 1.87 |
OSCC patients | ||||
Age | 1.03 | 0.201 | 0.98 | 1.08 |
Multiple vs single oral subsite OSCCs | 0.55 | 0.391 | 0.14 | 2.13 |
Smokers vs Non-smokers | 0.17 | 0.021 | 0.04 | 0.76 |
Drinkers vs Non-drinkers | 0.72 | 0.617 | 0.20 | 2.63 |
Gender (female vs male) | 1.03 | 0.973 | 0.24 | 4.39 |
Non-smoker patients | ||||
Age | 1.12 | <0.0005 | 1.05 | 1.19 |
OSCCs vs OPMDs | 73.06 | <0.0005 | 11.20 | 476.55 |
Multiple vs single oral subsite OPMDs/OSCCs | 0.28 | 0.138 | 0.05 | 1.50 |
Drinkers vs Non-drinkers | 1.15 | 0.883 | 0.19 | 7.09 |
Gender (female vs male) | 0.41 | 0.371 | 0.06 | 2.93 |
Smoker Patients | ||||
Age | 1.00 | 0.929 | 0.97 | 1.03 |
OSCCs vs OPMDs | 4.21 | 0.002 | 1.72 | 10.27 |
Multiple vs single oral subsite OPMDs/OSCCs | 0.24 | 0.005 | 0.09 | 0.65 |
Drinkers vs Non-drinkers | 0.80 | 0.578 | 0.36 | 1.76 |
Gender (female vs male) | 0.70 | 0.399 | 0.30 | 1.61 |
aOral potentially malignant disorders, OPMDs.
bOral squamous cell carcinomas, OSCCs.
cP- values <0.05 are in bold.
dDysplastic oral potentially malignant disorders, D-OPMDs.
eNon dysplastic oral potentially malignant disorders, ND-OPMDs.